Literature DB >> 6308505

Cyclic nucleotide distribution within rat striatonigral neurons.

M A Ariano, S K Ufkes.   

Abstract

Adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate have differential immunohistochemical distributions within retrogradely-labeled striatonigral neurons of the rat. Adenosine cyclic 3',5'-monophosphate is localized within more than half of the striatonigral projection neurons. It is also within the cytoplasm of other neurons and oligodendroglia. Guanosine cyclic 3'-5'-monophosphate is localized within 80% of the identified striatonigral neurons. These large percentages of cyclic nucleotide immunoreactivity within the striatonigral neurons suggest some of these efferent cells must contain both cyclic nucleotides. The immunofluorescent staining for guanosine cyclic 3',5'-monophosphate is almost identical to that reported for efferent neurotransmitter-containing neurons of the caudate nucleus. However, the large proportion of striatonigral neurons demonstrating guanosine cyclic 3',5'-monophosphate immunoreactivity precludes the association of the cyclic nucleotide with a selective neurotransmitter agent. Adenosine cyclic 3',5'-monophosphate-reactive elements are very different in staining appearance from guanosine cyclic 3',5'-monophosphate and neurotransmitter-identified somata. The number of striatonigral cells exhibiting reaction for this cyclic nucleotide does not eliminate the possibility that adenosine cyclic 3',5'-monophosphate might be preferentially co-localized with a specific neurotransmitter, such as gamma-aminobutyrate, as has been previously suggested through biochemical experimentation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308505     DOI: 10.1016/0306-4522(83)90043-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Direct visualization and cellular localization of D1 and D2 dopamine receptors in rat forebrain by use of fluorescent ligands.

Authors:  M A Ariano; F J Monsma; A C Barton; H C Kang; R P Haugland; D R Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

2.  A new approach to the immunocytochemistry of cAMP. Initial characterization of antibodies against acrolein-fixed cAMP.

Authors:  J De Vente; J Schipper; H W Steinbusch
Journal:  Histochemistry       Date:  1993-06

3.  Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission.

Authors:  Sara Arcangeli; Alessandro Tozzi; Michela Tantucci; Cristiano Spaccatini; Antonio de Iure; Cinzia Costa; Massimiliano Di Filippo; Barbara Picconi; Carmen Giampà; Francesca Romana Fusco; Salvatore Amoroso; Paolo Calabresi
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-14       Impact factor: 6.200

4.  Nitric oxide/cGMP pathway stimulates phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, in the substantia nigra.

Authors:  K Tsou; G L Snyder; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  Effect of chlorpromazine on the localization of cAMP phosphodiesterase.

Authors:  J C Seegers; M Haag; O J van Heerden; W S Joubert; J J Theron
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.